Related Experiment Videos
Choledochoduodenostomy for benign and malignant biliary tract diseases
S Birkenfeld1, F Serour, S Levi
1Department of Surgery, Edith Wolfson Hospital, Holon, Israel.
Surgery
|April 1, 1988
Summary
Choledochoduodenostomy (CDS) is a safe and effective surgical option for benign and malignant biliary diseases, offering excellent long-term outcomes, especially in elderly, high-risk patients. This procedure demonstrates low complication rates and mortality, making it a definitive treatment choice.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Hepatology
Background:
- Nonsurgical treatments for common bile duct stones exist, but choledochoduodenostomy (CDS) use has increased.
- Indications for CDS have expanded over the last decade.
- CDS is a surgical procedure connecting the common bile duct and the duodenum.
Purpose of the Study:
- To evaluate the safety and efficacy of side-to-side choledochoduodenostomy (CDS).
- To assess long-term outcomes in patients with benign and malignant biliary diseases.
- To analyze perioperative mortality and complication rates.
Main Methods:
- Retrospective analysis of 116 patients undergoing side-to-side CDS.
- Patients were categorized into benign (65) and malignant (46) biliary disease groups.
- Follow-up included assessment of complications and long-term results.
Main Results:
- For benign diseases (mean age 66.8 years), perioperative mortality was 3.07% with excellent long-term results and no biliary complications.
- For malignant obstructions, perioperative mortality was 8.6%, with no stomal invasion complications and only one case of ascending cholangitis.
- The procedure proved effective in high-risk, elderly patients.
Conclusions:
- Choledochoduodenostomy (CDS) is a relatively safe and definitive procedure for both benign and malignant biliary diseases.
- CDS offers good long-term results, particularly in high-risk, aged populations.
- The study supports the continued use of CDS in selected patients.